Eyecare products company Bausch + Lomb files for IPO

DMCA / Correction Notice
- Advertisement -

Bausch + Lomb, a Canadian manufacturer of contact lenses and eyecare products, filed for an IPO.

- Advertisement -

Why this matters: This could be the first mega-IPO of 2022 with Renaissance Capital assessment of That the issuer could raise up to $3 billion.

Description: Bausch + Lomb plans to list on both the NYSE and the Toronto Stock Exchange, and reports net income of $139 million on more than $2.7 billion in revenue for the first nine months of 2021.


Backstory: First reports last April That parent company Bosch Health (NYSE:BHC) was seeking to sell all or part of the eyecare business, which it bought from Warburg Pincus in 2013 for $8.7 billion, with prices in the $20 billion to $30 billion range. Was.

  • It confirmed spinoff plans in August, shortly after which a direct list was made by Warby Parker, which has begun to expand into contact lenses.

Bottom-line: “Founded in 1853, Bausch & Lomb is an iconic name in eye care. The company invented Ray-Ban sunglasses for military pilots and later introduced the first mass-produced soft contact lenses and contact-lens solutions ” , wall street journal

- Advertisement -

go in: Private equity giant TPG (finally) goes public


- Advertisement -

Stay on top - Get the daily news in your inbox

Recent Articles

Related Stories